Stock Comparison

ALNY vs VRTX

Alnylam Pharmaceuticals Inc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

ALNY

Alnylam Pharmaceuticals Inc

Healthcare

VRTX

Vertex Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$30.70B

$123.94B

P/E (TTM)

40.0

28.5

Forward P/E

26.4

25.7

Price/Sales

6.4

9.9

Price/Book

22.7

6.1

EV/EBITDA

26.0

23.2

Dividend Yield

—

Profitability

Net Margin

13.46%

35.40%

Operating Margin

17.54%

38.97%

Return on Equity

96.60%

23.50%

Return on Assets

12.30%

11.90%

Growth (YoY)

Revenue Growth

66.90%

12.50%

Earnings Growth

0.00%

8.00%

Price & Risk

Beta

0.3

52-Week High

$491.22

$529.65

52-Week Low

$205.48

$376.62

Analyst Target

$375.76

$559.28

Compare ALNY and VRTX your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.